BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 309932)

  • 1. Problems involved in grading the severity of hemophilia by test results.
    Kaneda T; Nagayama M; Minato F; Nakahira H; Nakajima J; Shikimori M
    J Oral Surg; 1978 Dec; 36(12):956-9. PubMed ID: 309932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemophilias today (author's transl)].
    Graf J
    Schweiz Rundsch Med Prax; 1979 Jan; 68(1):5-7. PubMed ID: 310549
    [No Abstract]   [Full Text] [Related]  

  • 4. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
    Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood platelets of hemophilia patients].
    Weibbbach G; Bührdel P; Domula M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(1):131-43. PubMed ID: 4128511
    [No Abstract]   [Full Text] [Related]  

  • 6. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1.
    Girolami A; Dal Bo Zanon R; Procidano M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dentition restoration in hemophilia under substitution of AHG concentrates].
    Tetsch P; Esser E
    Dtsch Zahnarztl Z; 1972 May; 27(5):399-404. PubMed ID: 4112700
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thromboplastin generation test and possible errors in its reproducibility].
    Tarasova LN
    Lab Delo; 1980; (11):669-71. PubMed ID: 6160299
    [No Abstract]   [Full Text] [Related]  

  • 9. Endogenous clotting factor activity and long-term outcome in patients with moderate haemophilia.
    Fischer K; van der Bom JG; Mauser-Bunschoten EP; Roosendaal G; Beek FJ; de Kleijn P; Grobbee DE; van den Berg HM
    Thromb Haemost; 2000 Dec; 84(6):977-80. PubMed ID: 11154144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The factor VIII complex: hemophilia A and von Willebrand disease].
    Tobelem G; Rothschild C
    Sem Hop; 1982 Sep; 58(35):2032-6. PubMed ID: 6293093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical observations and their relationship to laboratory findings in the haemophilias.
    Rainsford SG; Hall A
    Thromb Diath Haemorrh; 1975 Dec; 34(3):734-9. PubMed ID: 1082180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining severity of hemophilia: more than factor levels.
    Pavlova A; Oldenburg J
    Semin Thromb Hemost; 2013 Oct; 39(7):702-10. PubMed ID: 24026911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of deep soft tissue bleeding and hemarthrosis in hemophilia.
    Miller EH; Flessa HC; Glueck HI
    Clin Orthop Relat Res; 1972; 82():92-107. PubMed ID: 5011042
    [No Abstract]   [Full Text] [Related]  

  • 15. The management of bleeding in hemophilia.
    Abildgaard CF
    Adv Pediatr; 1969; 16():365-90. PubMed ID: 4899062
    [No Abstract]   [Full Text] [Related]  

  • 16. Bleeding symptoms in carriers of hemophilia A and B.
    Mauser Bunschoten EP; van Houwelingen JC; Sjamsoedin Visser EJ; van Dijken PJ; Kok AJ; Sixma JJ
    Thromb Haemost; 1988 Jun; 59(3):349-52. PubMed ID: 2847347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Capacity of activation of so-called deficient factors in hereditary blood coagulation disorders].
    Mingers AM
    Fortschr Med; 1976 Oct; 94(30):1723-5. PubMed ID: 1086815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraarticular bleeding in children with hemophilia: the prevention of arthropathy.
    Gregosiewicz A; Wośko I; Kandzierski G
    J Pediatr Orthop; 1989; 9(2):182-5. PubMed ID: 2494223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hemophilia.
    Rodeghiero F
    Ric Clin Lab; 1985; 15(4):289-303. PubMed ID: 3914697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postsurgical hemorrhage resulting from a drug-induced circulating anticoagulant: report of case.
    Nersasian RR; Rosner T; Gilmore W
    J Oral Surg; 1980 Sep; 38(9):688-90. PubMed ID: 6967961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.